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Abstract
Background: To provide a comprehensive overview of temporal trends in cancer incidence during 1973–2010 in
urban Shanghai.
Methods: The estimated annual percent changes (EAPCs) for the whole period and for the time segments in
age-standardized incidence rates (ASR) were evaluated with Joinpoint analysis. Age-period-cohort (APC) models
were modeled to examine the effects of age, period and birth cohort on cancer incidence.
Results: The overall ASR decreased slightly and significantly in males (EAPC of −0.41) but increased significantly
in females (EAPC of 0.57) during 1973–2010 in urban Shanghai. The incidence trend was not linear and varied by
time segments. During the most recent 10 years (2001–2010), the ASR in males decreased by 1.65 % per year and
stabilized in females. Incidence rates continued to decline during 1973–2010 for esophagus, stomach, and liver
cancer in both sexes, as well as male lung cancer and cervix cancer. It should be noted that it was the first time
to document a significant decline in lung cancer incidence among males during 1973–2010 with EAPC of −0.58 %,
and a notable upward for cervix cancer since 1996 with EAPC of 8.94 %. Unfavorable trends in incidence were
observed for the most common cancer sites in the 38 years period: colorectum, gallbladder & biliary tract,
pancreas, kidney, bladder, brain & central nervous system (CNS), thyroid, non-Hodgkin’s lymphoma (NHL),
prostate, female breast, corpus uteri, and ovary. APC analysis showed age, period and birth cohort yielded
different effects by cancer sites.
Conclusions: The observed trends primarily reflect dramatic changes in socioeconomic development and
lifestyles in urban Shanghai over the past four decades.
Keywords: Cancer incidence, Time trend, Age-period-cohort analysis, Shanghai
Background
The population-based cancer registry is an indispensable
tool for providing data for planning and evaluation of
programs for cancer control. There is no national cancer
reporting system and a few local cancer registries have
collected data on cancer incidence long enough to allow
the analysis of sequential trends in China [1]. Sufficiently
long period and high-quality population-based data have
been collected throughout Shanghai urban areas since
1970s by the Shanghai Cancer Registry (SCR) and pub-
lished periodically in volumes IV-X of “Cancer Incidence
in Five Continents (CI5)” by the International Agency for
Research on Cancer (IARC) [2, 3]. Cancer incidence
trends in urban Shanghai were reported previously [4, 5],
however, the data were outdated. Shanghai has experi-
enced rapid changes in aging population, economic devel-
opment, and social transformation over the past two
decades. This will absolutely bring great impact on the
cancer patterns and variation trends of cancers.
The current study examined the temporal changes on
age-adjusted cancer incidence rates and change points in
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long-term trends for all cancers combined and for the
top 18 site-specific cancers from 1973 through 2010 in
urban Shanghai by sex. This report also quantified the
effects of age, period, and birth cohort on the observed
trends with age-period-cohort (APC) analysis. The com-
prehensive analysis of cancer variation trends in a long
history perspective can not only provide basic informa-
tion for making the planning and prioritization of pre-
vention activities, but also to spur additional research
into the causes of these observed changes.
Methods
All cancer incidence data were derived from the SCR, an
associate member of the International Association of Can-
cer Registries (IACR). Details of the cancer registry have
been previously described [4, 6]. Briefly, the SCR, a
population-based cancer registry, systematically collected
information on incident cases of cancer in urban Shanghai
and the complete incidence data are available from 1973
onward [7]. In 2010, urban Shanghai had a total perman-
ent population of 6.19 million. The SCR has formed
standard system to collect, process, and report cancer
incidence data. A standardized notification card, which
includes information on name, date of birth, sex, ad-
dress, occupation, primary site of cancer, and date and
basis of cancer diagnosis, is used for reporting cancer
cases. The completeness of coverage of the Registry is
very high with death certification only (DCO) less than
1 %. The data has been published in the last six vol-
umes of Cancer incidence in Five Continents. The cor-
responding population data of Shanghai urban areas
were retrieved from the Shanghai Municipal Bureau of
Public Security. The study was approved and the need
for consent was waived by the institutional review
board (IRB) of Shanghai Municipal Center for Disease
Control & Prevention. In this study, only data in annual
cancer report was used and no information to identify
individual subjects was included.
Age standardized rates (ASRs) were calculated by the
direct method using the weight of the 1960 world stand-
ard population. The estimated annual percent changes
(EAPCs), representing the average percent increase or
decrease in cancer rates per year over a specified period
of time, were obtained using the joinpoint regression.
The joinpoint analysis has been widely applied to detect
the changes points (joinpoints) and determine the trends
between join points, which involves fitting a series of
joined straight lines on a logarithmic scale to the trends
in annual ASRs [8]. The allowed maximum number of
joinpoints was 5 over 38 years as at least 6 years was re-
quired for each segment. We used a Joinpoint regression
model implemented in the Joinpoint Regression Program
(Version 4.0.4) [9].
To further elucidate the trends in incidence rates of
all cancer combined and different cancer sites, age-
period-cohort (APC) analysis [10, 11] based on Poisson
regression for the effect of cohort and period, were
undertaken. A Lexis diagram tabulating incidence cases
and person-years by age, period and cohort was used
for the analysis. The formulation of the multiplicative
age-period-cohort model for incidence rates, (a,p) at
age a in period p for persons in cohort c = p - a, is:
log[r (a,p)] = f (a) + g(p) + h(c), where the additive ef-
fects can be partitioned into linear and nonlinear com-
ponents [12, 13]. Each of the three functions, f (a), g(p)
and h(c), were parameterized using natural splines
[12–14]. On adding together the linear and curvature
components, the individual categories of each effect
were obtained. The relevant sub-models were arranged
into a sequence to provide relevant comparisons of lin-
ear, non-linear cohort and period effects. Significant
curvatures in cohort and period effects was assessed by
comparing the differences in the deviances with the
degrees of freedom using Chi-square test [11]. The
statistical analysis was conducted using the apc.fit im-
plemented on the Epi package [15] from software R
version 3.0.1. Statistical significance was attributed to
two-sided P values <0.05.
For APC analysis of subtypes of cancer, except for
esophagus and prostate, an age restriction to ages 20–84
eliminated some of the variation caused by few cases
among younger ages and potential biases concerning the
accuracy in the oldest age groups. Synthetic twenty 5-
year birth cohorts were derived on subtracting the mid-
points of the 5-year age groups 20–24, 25–29, 30–34, …,
80–84 from the central year of the 5-year periods of
diagnosis 1973–1975, 1976–1980, …, 2006–2010. The
mid-point of birth cohort (1937–1941) was set as a ref-
erence cohort. For esophagus and prostate, because of
the huge variation of scale in APC graphs, we restricted
the APC analysis to those aged 30–84 and birth cohorts
was obtained by subtracting the midpoints of 5-year age
groups from the corresponding calendar year, having the
reference cohort of 1932–1936.
Availability of data
We are unable to share the data owing to the grounds of
our ethics approval. Most of data supporting the conclu-
sions of this article is available in the Cancer Incidence
in Five Continents (CI5) series: Cancer Incidence in Five
Continents Volumes I to X by IARC (http://ci5.iarc.fr/
CI5I-X/Default.aspx),
Results
As shown in Table 1, during the most recent time period,
2006–2010, 122,341 cases of cancer were diagnosed
among residents of urban Shanghai. The crude incidence
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Table 1 Temporal trends for cancer incidence rates by sex and selected cancer sites in urban Shanghai, 1973–2010
Sites ICD-10 Male Female
1973–1977 2006–2010 Percent changeb EAPCc 1973–1977 2006–2010 Percent changeb EAPCc
Count ASRa Count ASR Count ASR Count ASR
Nasopharynx C11 662 4.20 811 3.01 −28.38 −0.49 351 2.14 306 1.12 −47.81 −1.71*
Other oral cavity and pharynx C00-10,C12-14 374 2.63 814 2.71 2.87 0.04 340 2.14 569 1.78 −16.68 −0.42*
Esophagus C15 3381 25.31 1911 5.62 −77.81 −4.23* 1659 10.48 781 1.60 −84.75 −5.45*
Stomach C16 8263 59.12 7992 24.20 −59.06 −2.66* 3853 24.05 4681 12.81 −46.74 −1.84*
Colorectum C18-20 1898 13.58 9252 28.36 108.85 2.37* 1913 11.92 8222 22.33 87.33 2.13*
Liver C22 5289 34.77 6129 19.94 −42.64 −1.56* 1929 11.91 2459 6.41 −46.17 −1.76*
Gallbladder & biliary tract C23-24 148 1.12 1020 2.94 162.14 3.15* 280 1.73 1684 3.91 125.73 2.80*
Pancreas C25 597 4.18 2436 7.33 75.27 1.67* 523 3.31 2174 5.39 62.89 1.61*
Larynx C32 429 3.12 768 2.39 −23.51 −0.69* 101 0.65 44 0.11 −82.98 −4.88*
Lung C33-34 6752 48.51 12986 38.13 −21.39 −0.58* 2885 18.02 6667 17.76 −1.47 0.14
Bone C40-41 304 2.08 237 1.03 −50.38 −2.05* 263 1.64 237 0.95 −41.84 −1.43*
Other skin C44 237 1.82 651 2.01 10.46 0.50 227 1.45 577 1.59 9.51 0.53
Breast C50 55 0.36 77 0.25 −29.45 −0.44 2807 17.14 11296 39.51 130.51 2.89*
Cervix C53 – – – – – – 3163 19.02 1271 5.30 −72.16 −3.44*
Corpus uteri C54 – – – – – – 416 2.43 1746 5.86 141.28 3.06*
Ovary C56 – – – – – – 665 4.09 1938 7.10 73.57 2.07*
Prostate C61 187 1.62 4453 12.17 651.27 6.89* – – – – – –
Kidney & renal pelvis C64-66 172 1.27 2466 8.41 562.05 6.41* 135 0.93 1305 4.06 336.50 5.42*
Bladder C67 828 6.49 2609 7.72 18.93 0.82* 318 2.01 889 2.18 8.64 0.59*
CNS C70-72 494 3.50 1496 6.01 71.77 1.85* 436 3.03 1878 6.49 114.05 2.99*
Thyroid C73 285 1.80 1045 4.58 154.41 2.77* 850 5.26 3439 14.78 180.96 3.47*
Hodgkin lymphoma C81 127 0.86 66 0.36 −57.70 −1.71* 82 0.51 32 0.14 −72.33 −2.82*
NHL C82-85,C96 491 3.43 1409 5.05 47.13 1.64* 284 1.77 1139 3.65 106.48 2.50*
Multiple myeloma C88 + C90 81 0.52 471 1.47 183.41 3.01* 65 0.38 314 0.83 119.15 2.83*
Leukemia C91-95 681 4.99 1269 5.47 9.68 0.13 587 4.17 1003 4.23 1.43 −0.17
All sites C00-95 33629 239.03 64015 202.13 −15.44 −0.41* 26287 163.81 58326 181.76 10.96 0.57*











rates for all cancer sites were 414.81 per 100,000 (ASR:
202.13) in males and 378.26 per 100,000 (ASR: 181.76) in
females, with a male-to-female sex ratio of 1.10:1. Lung,
colorectal, stomach, liver, and prostate cancers were the
five top types of cancer among males. Among females, the
five most common sites of cancer were breast, colorectal,
lung, stomach, and thyroid.
Trends in ASRs
Table 2 showed the long-term trend and trend patterns
for all cancer combined and for the eighteen common
cancer sites based on the joinpoint analysis by sex from
1973 to 2010. Among males, incidence rates for all can-
cers combined slightly but significantly decreased by an
estimated annual percent change (EAPC) of −0.41 %. In
contrast to males, a statistically significant increase of
0.57 % per year was noted among females, despite the
lower average incidence compared with males. For male
incidence, there were two joinpoints at 1996 and 2001:
the rate decreased by −0.79 % per year from 1973 to
1996, stabilized from 1996 to 2001, and decreased by
−1.65 % per year from 2001 to 2010. For females, there
were three joinpoints at 1980, 1996 and 2001: the rate
decreased by −3.01 % annually from 1973 to 1980, stabi-
lized from 1980 to 1996, increased by 4.38 % annually
from 1996 to 2001, then remained unchanged from 2001
to 2010.
Throughout the whole 38-year time period, the inci-
dence rates had increased steadily since 1973 for 5 com-
mon cancer sites: pancreas (EAPC: 1.67 % for males,
1.61 % for females), kidney & renal pelvis (EAPC: 6.41 %
for males, 5.42 % for females), bladder (EAPC: 0.82 %
for males, 0.59 % for females), non-Hodgkin lymphoma
(NHL) (EAPC: 1.64 % for males, 2.50 % for females),
and colorectal cancer in males (EAPC, 2.37 %). Unfavor-
able trends in incidence were also observed for gallblad-
der & biliary tract (EAPC: 3.15 % for males, 2.80 % for
females), brain & central nervous system (CNS) (EAPC:
1.85 % for males, 2.99 % for females), thyroid (EAPC:
2.77 for males, 3.47 % for females), colorectal in females
(EAPC: 2.13 %), corpus uteri (EAPC: 3.06 %), and ovary
(EAPC: 2.07 %) cancers during the observed period. The
rates for these cancers, except for thyroid cancer,
reached a peak and had declined or stabilized in the
most recent 10 years. Trends pattern in thyroid cancer
was more complex- decreasing before early 1980s at an
annual rate of −15.81 % in males and −9.58 % in females,
then increasing afterwards with a larger rate in the most
recent 10 years accelerating to 18.10 % in males and
17.72 % in females, respectively.
In contrast, continuous decreases in incidence rates of
esophagus (EAPC: −4.23 % for males, −5.45 % for fe-
males), stomach (EAPC: −2.66 % for males, −1.84 % for
females), and liver (EAPC: −1.56 % for males, −1.76 %
for females), cancers were observed, with almost no dif-
ference between males and females.
Lung cancer remained the most common cancer in
males, while a slight but significant decrease at an an-
nual rate of −0.58 % during 1973–2010 was seen. Male
lung cancer tended to decline substantially in the most
recent 10 years at an annual rate of −3.45 %. Among fe-
males, although the incidence was relatively stable over
the whole period, the rates in females showed signs of
decreasing since 2001 with an EAPC of −1.89 %. Regard-
ing the trends for leukemia, the incidence appeared to
be steady over the years, which seemed rather stable in
male. For females, the rates had increased steadily since
1997 at an annual rate change of 2.13 %.
There had been a marked increase in incidence for
prostate cancer during the four decades with EAPC ap-
proaching 6.89 %. The very sharp increase (EAPC
12.62 %) detected between 1989 and 2004 seemed to have
slowed down in recent years. Trends in incidence from fe-
male breast cancer and cervical cancer were different with
an increase of 2.59 % per year and a decline of −3.44 %
per year from 1973 through 2010. Female breast cancer
was upward before 2001 with a sharp increase by 7.91 %
per year in 1996–2001 and then reached a plateau during
the recent 10 years. The decline in incidence for cervix
cancer was steep until 1996, when trends reversed and
significantly increased by 8.94 % per year.
Age-period-cohort analysis for selected cancers
The effects of age, period and cohort on incidence rates
by cancer sites according to sex were displayed in Figs. 1
and 2.
Three main patterns of evolution were observed for
cohort effects: the first group with four cancer sites
(esophagus, stomach, and liver cancers) in both sexes, in
which incidence trends were consistent downward
throughout all birth cohorts; the second group com-
prised of colorectum in male, prostate, kidney & renal
pelvis, NHL, thyroid, female breast, ovary, and corpus
uteri cancers, in which all successive birth cohorts expe-
rienced a steady rise in the risk of developing cancer,
with no clear evidence of downward trend for the youn-
ger generations; the third group with colorectum in fe-
male, gallbladder & biliary tract, pancreas, bladder, and
CNS cancers, in which incidence fluctuated in all birth
cohorts and showed a upward trend generally.
The lung cancer incidence rates in both sexes were ac-
celerated in birth cohorts born in the early 1900s, and
then declined in 1930, followed with further accelerations
in about 1945 and deceleration rates in the 1960s. A dif-
ferent pattern of birth cohort effect of cervix cancer was
observed: a declining risk till later 1940s, then a steady ris-
ing risk in every later consecutive birth cohorts.
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Table 2 Time period for temporal trends in age-adjusted cancer incidence for selected cancers by sex in Shanghai, 1973–2010
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
EAPC\(%)a Years EAPC(%) Years EAPC(%) Years EAPC(%) Years EAPC(%) Years EAPC(%)
All sites
Male −0.41* 1973–1996 −0.79* 1996–2001 2.29 2001–2010 −1.65*
Female 0.57* 1973–1980 −3.01* 1980–1996 0.30 1996–2001 4.38* 2001–2010 −0.14
Esophagus
Male −4.23* 1973–1994 −5.14* 1994–2001 −0.39 2001–2010 −6.58*
Female −5.45* 1973–2010 −5.45*
Stomach
Male −2.66* 1973–1989 −1.67* 1989–1995 −5.36* 1995–2000 0.44 2000–2010 −4.23*
Female −1.84* 1973–1989 −1.00* 1989–1995 −3.84* 1995–2000 1.16 2000–2010 −3.88*
Colorectum
Male 2.37* 1973–2010 2.37*
Female 2.13* 1973–1995 2.15* 1995–2002 4.18* 2002–2010 −1.65*
Liver
Male −1.56* 1973–1996 −1.77* 1996–2002 0.79 2002–2010 −3.97*
Female −1.76* 1973–2010 −1.76*
Gallbladder & biliary tract
Male 3.15* 1973–2000 4.44* 2000–2010 −2.31
Female 2.80* 1973–1987 5.53* 1987–1995 1.87 1995–2000 6.68 2000–2010 −3.72*
Pancreas
Male 1.67* 1973–1982 4.00* 1982–2010 1.25*
Female 1.61* 1973–2010 1.61*
Lung
Male −0.58* 1973–1989 0.79* 1989–1994 −2.93 1994–1999 2.52 1999–2010 −3.45*
Female 0.14 1973–1995 −0.29 1995–2001 3.07 2001–2010 −1.89*
Kidney & renal pelvis
Male 6.41* 1973–1981 −1.03 1981–2010 7.54*
Female 5.42* 1973–1980 −4.48 1980–2010 6.60*
Bladder
Male 0.82* 1973–2010 0.82*
Female 0.59* 1973–1991 −0.89 1991–2010 1.97*
CNS
Male 1.85* 1973–1980 −1.09 1980–1989 5.57* 1989–2010 0.52
Female 2.99* 1973–1980 −2.28 1980–1985 8.54 1985–2003 3.31* 2003–2010 −1.67
Thyroid
Male 2.77* 1973–1978 0.85 1978–1983 −15.81* 1983–2001 3.60* 2001–2010 18.10*
Female 3.47* 1973–1984 −9.58* 1984–2002 5.57* 2002–2010 17.72*
NHL
Male 1.64* 1973–2010 1.64*
Female 2.50* 1973–2010 2.50*
Leukemia
Male 0.13 1973–2010 0.13
Female −0.17 1973–1997 −1.09* 1997–2010 2.13*
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During the period 1973–2010, the trend of period effect
was oscillating in each of cancer sties. The period rate
ratios remained stable for most of common cancer sites
(esophagus, stomach, colorectum, liver, pancreas, lung,
kidney & renal pelvis, bladder, CNS, NHL, leukemia, pros-
tate, female breast, corpus uteri, and ovary). APC models
showed a strong period effect in both sexes for thyroid
cancer, which decreased through the early 1980s, then
increased thereafter. The period effect in cervix cancer
also yielded significant transitions in incidence trends: a
falling trend up to the mid-1990s and a rising trend after
the early 2000s.
Discussion
This study provided a comprehensive and up-to-date
overview of temporal trends and the age-period-cohort ef-
fects on cancer incidence in urban Shanghai over the past
four decades. Regarding trends for all cancers combined,
the incidence declined slightly and significantly in males
during the whole period of 1973–2010, but a statistically
significantly increased trend was noted in females. During
the most recent 10 years (2001–2010), the overall cancer
incidence rates in males decreased by 1.65 % per year, but
stabilized in females. The results showed that the trends
and change points for incidence trends varied by cancer
Table 2 Time period for temporal trends in age-adjusted cancer incidence for selected cancers by sex in Shanghai, 1973–2010
(Continued)
Prostate 6.89* 1973–1989 0.51 1989–2004 12.62* 2004–2010 3.59
Female breast 2.89* 1973–1981 −0.17 1981–1990 4.45* 1990–1996 0.77 1996–2001 7.91* 2001–2010 0.23
Cervix −3.44* 1973–1980 −19.07* 1980–1996 −6.99* 1996–2010 8.94*
Corpus uteri 3.06* 1973–1996 2.52* 1996–2001 10.24* 2001–2010 −2.00
Ovary 2.07* 1973–1984 −0.55 1984–2005 3.50* 2005–2010 −5.66
aEAPC: estimated annual percent change in age-adjusted incidence rates, from join point analysis using Joinpoint software. *Estimated annual percentage change
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Fig. 1 Estimated Age-Period-Cohort effects for incidence of selected cancers in urban Shanghai (1973–2010) among males Note: Age-period-
cohort effects, with confidence limits, on incidence from common cancer sites in urban Shanghai. Each graph has three curves depicting, from
left to right, trends in incidence rate by age for the reference cohort (age effect), incidence risk by birth cohort (cohort effect,taking 1937–1941 or
1932–1936 as the reference) and incidence risk by calendar year (period effect, taking the incidence average of the period as the reference). The
graph has the horizontal axis divided into two parts: one for age (years old) and one for cohort-period (calendar years). The left vertical axis
represents incidence rates for the age effect and the right vertical axis represents the relative risk for the cohort and period effect. The drift is
added to the non-linear birth cohort effects and the right plot presents the period effect as residual ratio rates
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sites, and the age, period and birth cohort also yielded
different effects by cancer types. The trend patterns could
be predicted by both time periods of diagnosis and birth
cohort components. The cancer types which were com-
mon among males and females had similar trends and the
trends had no significant difference according to EAPC
values, except for lung cancer.
Scrutiny of trends in cancer incidence can help to
recognize trends related to changes in cancer risk, in-
cluding risks mediated by exposures to environmental
and occupational carcinogens. With its diversity as an
asset, Shanghai has enjoyed remarkable economic growth
in the last four decades, experiencing rapid changes in
population aging, urbanization, and social transformation,
which could bring great impact on cancer patterns and
variation of temporal trends. The particular tumors
selected that may be influenced by these changes were dis-
cussed below.
Esophagus and stomach cancers showed a remarkable
and steady decrease in incidence over the study period,
and the trends were also reflected in the gradual decline
in risk in successive generation among both sexes born
approximately after 1900. The decrease in esophageal and
stomach cancer rates in both males and females can be ex-
pected to continue in consideration of the sharp decline in
younger birth cohorts. The patterns were likely to be at-
tributable to the general improvements in living condi-
tions in Shanghai, such as increasing consumption of
fresh fruit and vegetables, the widespread use of refriger-
ation, and decreasing intake of salt-preserved food and
beverage at high temperatures [5, 16]. Other possible de-
terminants for the favorable trends of stomach cancer
were reductions in infection of Helicobacter pylori because
of improvements in socioeconomic status and sanitary
conditions of housing [5].
Colorectal cancer was one of the most rapidly increas-
ing malignancies and it was the second most frequent
cancer in urban Shanghai. Previous studies have sug-
gested that maintenance of a healthy diet and avoidance
of a sedentary lifestyle and obesity may reduce the risk
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Fig. 2 Estimated Age-Period-Cohort effects for incidence of selected cancers in urban Shanghai (1973–2010) among females. Note: Age-period-cohort
effects, with confidence limits, on incidence from common cancer sites in urban Shanghai. Each graph has three curves depicting, from left to right,
trends in incidence rate by age for the reference cohort (age effect), incidence risk by birth cohort (cohort effect, taking 1937–1941 or 1932–1936 as
the reference) and incidence risk by calendar year (period effect, taking the incidence average of the period as the reference). The graph has the
horizontal axis divided into two parts: one for age (years old) and one for cohort-period (calendar years). The left vertical axis represents incidence rates
for the age effect and the right vertical axis represents the relative risk for the cohort and period effect. The drift is added to the non-linear birth cohort
effects and the right plot presents the period effect as residual ratio rates
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of colorectal cancer [17]. It thus appeared that the
changes in lifestyles, such as less physical activity, and
excess weight, may contribute to the persistently rising
rates in urban Shanghai [18, 19]. In the US, continuous
decline in colorectal cancer incidence in recent years
was most likely attributable to significant improvements
in the use of colorectal cancer screening [20]. A local
colorectal cancer screening program using biennial fecal
occult blood testing (FOBT), followed by total colonos-
copy in positive patients, has been implemented in
Shanghai since 2012, and this program will influence its
incidence trend in future.
Incidence from liver cancer was favorable for both sexes
over the whole period and the declines in risk have been
observed among successive birth cohorts born since 1915s
in urban Shanghai. Etiological determinants of liver cancer
include chronic infection with hepatitis B virus (HBV),
and exposure to dietary aflatoxin, alcohol consumption
and smoking [21, 22], all of which may partially contribute
to the decreasing trend. Measures to prevent HBV infec-
tion by managing blood and its products, and measures to
ensure an improved water quality by purifying polluted
water source, have largely decreased the risk of HBV in-
fection and aflatoxin B1, respectively [23]. Other measures
such as attempts to reduce the consumption of smoking
and heavy drinking, and a focus on a balanced diet [24,
25] may also be attributed to the risk downward of liver
cancer. The newborns in urban Shanghai have been
inoculated with the HBV vaccine under the aggressive vac-
cination program since 1992 [25], so further decreased
incidence will be seen in these children as they become
adults about 10–30 decades later [26]. It should be noted
that liver cancer incidence rates were increasing in many
parts of the world including the US and Central Europe,
possibly due to the obesity epidemic and the rise in hepa-
titis C virus (HCV) infection [27].
The incidence of pancreas cancer in urban Shanghai
has increased constantly since the 1970s, which is con-
sistent with the increasing rates among successive birth
cohorts. Factors that contributed to the increasing rates
in males and females were not fully elucidated. Limited
studies showed that improvement in the diagnosis of
pancreas cancer and changes in lifestyles (such as changing
of dietary patterns and increasing prevalence of obesity)
may partly explain the rising trend [28–31].
This study was the first to document a significant
slight decrease in lung cancer incidence among males
during the observed period in urban Shanghai, with ac-
companying more substantial decline in the most recent
10 years, a changing from a plateau to a gradual reduc-
tion. Similarly, although the incidence was relatively
stable in females over the whole period, an encouraging
trend after 2001 was observed. APC models also sug-
gested that incidence rates began to decline for younger
generations born around 1960. Therefore, the decreases
in lung cancer rates in both males and females can be
expected to continue with lower risk of younger birth
cohorts. Overwhelming majority of lung cancer was
caused by tobacco smoking, accounting for 80 % of the
worldwide lung cancer burden in males and at least
50 % of the burden in females [27]. The prevalence of
smoking among males tripled in China from the early
1950s to the late 1980s and reached 61 % in Shanghai
during 1970s [5]. The smoking prevalence in Shanghai
showed signs of stability or slight decreasing since 1970s
and estimated as 55.37 % among males and 1.47 %
among females aged 15 and above in 2010 [32]. Lung
cancer risk among women in urban Shanghai was linked
to smoking, as well as to exposure to rapeseed oil vapors
during high-temperature cooking [33]. The downward
trend observed in female lung cancer incidence in recent
10 years reflected the improvements in kitchen ventila-
tion and in living conditions. The risk of lung cancer
from cigarette consumption among males in Shanghai
may have been attenuated by some protective factors
such as intake of certain fruits and vegetables and by im-
provements in the work environment [5, 34].
Female breast cancer has increased substantially in
urban Shanghai, becoming the leading cancer among
females in the late 1980s. Population-based breast
cancer screening programs with effective tools such as
mammography and ultrasonography have yet to be im-
plemented in Shanghai. This substantial increase trend
in urban Shanghai was driven by cohort effects. Men-
strual and reproductive factors, such as early age at me-
narche, late age at first pregnancy, lack of lactation, and
decreasing number of children because of one-child-
per-family policy, may partially explain the increasing
trend of breast cancer [4, 35]. Other factors including
changes in lifestyles, such as high consumption of animal
foods and fat, less physical activity, and obesity, may be re-
lated to the rising incidence [16, 36]. In contrast, the bur-
den of cervical cancer substantially decreased over time.
Strong period and cohort effects were observed in its
trend. The dramatic decline in cervix cancer before 1996
could be largely attributed to the widespread Pap smear
screening and treatment programs first implemented in
Shanghai during the late 1950s [5, 37]. Notably, there
appeared a rising trend since 1996. Higher prevalence of
Human Papilloma virus (HPV), and changes in lifestyles
and sexual behaviors can be partially attributed to the ris-
ing risk among younger generations [38].
During the past four decades in urban Shanghai, pros-
tate cancer incidence rates have increased substantially.
The incidence rate was among the lowest in the world at
1970s and it became the fifth most common cancer in
males after 2002. APC analysis showed that cohort effect
increased steadily after the year corresponding to the
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minimum risk value, whereas period effect seemed to re-
main unchanged throughout the years. There has been
no national or local prostate cancer screening in Shang-
hai and the reasons for the upward trend may suggest a
role of environmental factors and/or increased detection
of the tumors based on improved technology and sur-
veillance [4].
Thyroid cancer incidence decreased through the early
1980s, then increased thereafter. The results from APC
modeling showed that both period and birth cohort effects
appeared to have an impact on the observed incidence
trends. The downward during the beginning 10 years may
be explained in part by the mass screening conducted in
several factories in the mid-1970s, which detected large
numbers of occult cancer cases in that period [4]. The im-
provement in diagnostic modalities and increased medical
detection of small thyroid nodules may contribute to the
unusual increase in the incidence during the last two
decades in both sexes. However, the effects of iodine sup-
plementation and some birth cohort-related changes in
environmental exposures (such as increased exposure to
diagnostic X-rays) cannot be ruled out for the observed
increased risk of thyroid cancer among young birth co-
horts. Same patterns in incidence of thyroid cancer were
found in the US and Denmark [39, 40]. Further detailed
analysis based on histopathology is needed to clarify the
potential contributors for the sharp upward of incidence.
Over the study period, the incidence of kidney &
renal pelvis cancer had risen rapidly since the 1970s.
Accumulating evidences have suggested an etiologic
role in renal cell carcinoma for physical activity, alcohol
consumption, and occupational exposure to trichloro-
ethylene [41]. Among malignancies of the hematopoietic
system, a steady increase in incidence was observed for
NHL. No clear understanding of the risk factors can
explain the long-term trends. Increasing exposure to one
or more ubiquitous lymphomagenic agents [42] such as
pesticides may partly contribute to the upward in inci-
dence. Further researches are warranted to clarify the
potential risk factors for these cancers with increasing in-
cidence in urban Shanghai.
There were no substantial changes in the registry op-
eration occurred over the study period. It was plausible
that at least part of the observed trends on cancer inci-
dence may reflect changes in the prevalence of risk fac-
tors and the measures taken for cancer prevention and
control in the population. The incidence trends for all
cancers combined for males and females varied. The sig-
nificant download trend in males may be partly ex-
plained by the declines in several cancer rates, including
esophagus, stomach, liver, and lung cancer, while the in-
creased incidence of colorectum, breast, and thyroid
cancers could be partly attributed to the upward trend
in females.
Conclusions
In summary, the overall ASR decreased slightly and sig-
nificantly in males but increased significantly in females
from 1973 to 2010 in urban Shanghai. The incidence
trends were not linear for all cancers combined and for
common cancer sites and varied by time segments. The
observed trends could reflect dramatic changes in socio-
economic development and lifestyle in urban Shanghai
over the past four decades and underscore the need for
additional prevention efforts for the cancers with constant
increasing incidence or rising again.
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